Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

NCT05653349 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

226

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Immune Thrombocytopenia (ITP)

Interventions

BIOLOGICAL: Ianalumab
DRUG: Placebo
DRUG: Corticosteroids

Sponsor

Novartis Pharmaceuticals